Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Prostate Cancer treatment details. Immunotherapy. Kurume University School of Medicine, Kurume, Japan

Survival: 22.0 months
Toxicity Grade: 2
Treatments: Immunotherapy
Country: Japan
City/State/Province: Kurume
Hospital: Kurume University School of Medicine
Journal: Link
Date: 1/2004

Patients: This Phase I trial involved 10 patients with metastatic hormone refractory prostate cancer. All patients were also positive for human leukocyte antigen (HLA)-A2.

Treatment: The treatment consisted of immunotherapy a peptide vaccination.

Toxicity: All ten patients developed grade 1 or 2 local redness and swelling at the injection site.

Results: There were no objective responses of measurable disease, but median survival was 22 months.

Correspondence: M. Noguchi, MD

E-mail to a Friend Email Physician More Information